In a nutshell This study evaluated the side effects in patients with type 2 diabetes (T2D) after treatment with glimepiride (Amaryl). The authors found that while glimepiride lowered mortality, the rate of most side effects was the same as other similar drugs. Some background Treatments for T2D aim to lower blood glucose...
Read MoreIn a nutshell This study examined if glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs could reduce the rate of heart disease and stroke in patients with Type 2 diabetes (T2D). The authors found that fewer patients who received GLP-1RA drugs developed heart disease or stroke compared to those who received a placebo. Some background...
Read More
In a nutshell This study investigated the safety and effectiveness of albiglutide (Tanzeum) in preventing cardiovascular events (CVE) such as heart attacks and strokes in patients with type 2 diabetes (T2D) and heart disease. The main finding was that albiglutide reduced the risk of CVE in these patients. Some background Patients with...
Read More
In a nutshell This review analyzed different studies that evaluated the effect of antihypertensive agents (blood pressure-lowering drugs) on the onset and progress of diabetic kidney disease (DKD). Some background Diabetes mellitus (DM) is a condition which increases blood sugar levels in the body. Cardiovascular diseases (CVD), such as...
Read More
